Clinical trials: Osteoporosis, Steroid Induced
Osteoporosis
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
The purpose of the study is to learn if one year of treatment with parathyroid hormone (PTH), either alone or with risedronate, will increase the thickness of the bones in the hip and spine in subjects with osteoporosis from…
- Trial name
- NCT00221299
- Testing
- Risedronate, Parathyroid Hormone
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- University of California, Davis